Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Heron Therapeutics Inc (HRTX) vs Plby Group Inc (PLBY) Price & Performance

Heron Therapeutics IncTrade
Plby Group IncTrade

Price performance (Past 24H)

Key statistics

Heron Therapeutics Inc vs Plby Group Inc — how do they compare? Heron Therapeutics Inc trades at $0.46 (market cap $91.46M), while Plby Group Inc trades at $1.21 (market cap $139.87M). The key difference: Plby Group Inc is the larger of the two by market cap. Which is the better fit depends on your goals.

HRTXPLBY
Market Cap
$91.46M$139.87M
Sector
HealthConsumer Cyclical
52-Week High
$1.96$2.71
52-Week Low
$0.39$1.11
Enterprise Value
$189.36M$287.68M

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Heron Therapeutics Inc

No Aura AI signal available yet.

Plby Group Inc

PLBY Group trades at $1.23, up 5.13% today, amid a bearish technical signal. The company shows improving fundamentals with five consecutive quarters of positive adjusted EBITDA and narrowing losses, though it remains unprofitable. Recent developments include inclusion in the Russell 2000 and 3000 indices and a major share repurchase. Analyst consensus is strongly bullish with 75% buy ratings, reflecting optimism around the company's strategic focus on licensing, media, and experiences.

The outlook for PLBY hinges on sustaining its operational turnaround and achieving profitability. Key opportunities include brand monetization and cost management, while risks involve high debt levels and competitive pressures. Investors should weigh the strong analyst support against the company's historical losses and current negative equity position.

Returns comparison

Trailing returns across standard periods

About Heron Therapeutics Inc

Heron Therapeutics is a commercial-stage biotechnology company focused on improving patient care. It develops best-in-class medicines for pain management and cancer care to address unmet medical needs.

Read more on HRTX

About Plby Group Inc

PLBY Group Inc is a pleasure and leisure company. The company's segment includes Licensing, Direct-to-Consumer, and Digital Subscriptions and Content. It generates maximum revenue from the Direct-to-Consumer segment. Direct-to-Consumer operations include consumer products sold through third-party retailers or online direct-to-customer. Geographically, it derives a majority of revenue from the United States.

Read more on PLBY